Veradigm Inc. (NASDAQ:MDRX - Get Free Report)'s share price traded down 5% during trading on Wednesday . The stock traded as low as $7.60 and last traded at $7.60. 6,938 shares traded hands during trading, a decline of 98% from the average session volume of 373,263 shares. The stock had previously closed at $8.00.
Analyst Upgrades and Downgrades
Separately, StockNews.com started coverage on shares of Veradigm in a research report on Tuesday. They issued a "hold" rating for the company.
Get Our Latest Research Report on Veradigm
Veradigm Stock Performance
The business's 50-day simple moving average is $9.67 and its two-hundred day simple moving average is $9.65.
Veradigm Company Profile
(
Get Free Report)
Veradigm Inc, a healthcare technology company, provides information technology solutions and services to healthcare organizations in the United States, Canada, and internationally. It offers electronic health records (EHR), information connectivity, private cloud hosting, outsourcing, analytics, patient access, and population health management solutions.
See Also
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Veradigm, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Veradigm wasn't on the list.
While Veradigm currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
